Download Comparison of phototherapy two times and four times a

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

National Institute for Health and Care Excellence wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Hormesis wikipedia , lookup

Bad Pharma wikipedia , lookup

Ofloxacin wikipedia , lookup

Adherence (medicine) wikipedia , lookup

Theralizumab wikipedia , lookup

Dydrogesterone wikipedia , lookup

Bilastine wikipedia , lookup

Transcript
Entrez PubMed
Pagina 1 di 1
Comparison of phototherapy two times and four times a week with low doses
of narrow-band ultraviolet B in Asian patients with psoriasis.
Leenutaphong V, Nimkulrat P, Sudtim S.
Department of Dermatology, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
BACKGROUND/AIMS: The optimum narrow-band (TL-01) ultraviolet (UV) B weekly
treatment frequency for psoriasis has yet to be defined, especially in Asian patients with TL01. Our purpose was to compare 2 x weekly and 4 x weekly therapy with narrow-band UVB at
low doses for psoriasis vulgaris. METHODS: Sixty-nine patients with moderately severe
psoriasis were recruited and allocated to the 2 x weekly or 4 x weekly treatment group. The
patients were treated with a new protocol using low doses of narrow-band UVB with varied
exposure increments. Outcomes were evaluated by means of Psoriasis Area and Severity Index
(PASI) scores, time (weeks), cumulative UVB dose and number of treatments to clearance.
RESULTS: No significant difference was found between the two regimens in the PASI score
at the end of treatment, in the proportion of patients whose skin cleared during treatment and
in the time to clearance (8 weeks). Those who completed treatment achieved clearance after a
median of 16 exposures with 2 x weekly treatment compared with 32 exposures with 4 x
weekly treatment (P=0.0304), and 12.5 minimal erythema dose multiples (MEDs) compared
with 39.7 MEDs (P=0.0470). Acute side effects of the treatment were similar for the two
groups (P=0.8462). CONCLUSION: For skin phototype III-V populations, a greater long-term
risk is expected, connected with the higher cumulative UVB dose and number of exposures
required in the 4x weekly group. Therefore, 4 x weekly phototherapy will no longer be used
for psoriasis.
Publication Types:
Clinical Trial
Controlled Clinical Trial
PMID: 11068858 [PubMed - indexed for MEDLINE]
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A...
15/03/2006